// App-Quantinova.ai

P1346 : EVALUATION OF CURRENT NATIONAL PRACTICE IN THE PREVENTION OF PTLD POST PAEDIATRIC HSCT

Researchers

Presenter

  • Eleanor Kissane

Principal Investigators

  • Iman Sulevani

  • Beki James

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • Haematology,Leeds Teaching Hospital,Leeds,Reino Unido

  • University of Leeds,Leeds,Reino Unido

  • University of Leeds,Leeds,Verenigd Koninkrijk

  • University of Leeds,Leeds,Royaume-uni

  • University of Leeds,Leeds,Соединённое Королевство

  • Haematology,Leeds Teaching Hospital,Leeds,Reino Unido

  • Paediatric Haematology,Leeds Teaching Hospitals,Leeds,Vereinigtes Königreich

  • University of Leeds,Leeds,Storbritannien

  • University of Leeds,Leeds,Reino Unido

  • Haematology,Leeds Teaching Hospital,Leeds,Reino Unido

  • Paediatric Haematology,Leeds Teaching Hospitals,Leeds,United Kingdom

  • Paediatric Haematology,Leeds Teaching Hospitals,Leeds,Ve

  • University of Leeds,Leeds,Vereinigtes Königreich

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Post-transplant lymphoproliferative disorder

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved